ProNAi Therapeutics Inc (DNAI) has 11 open-market insider trades by 9 insiders since 2015. The most active filer is Chandra D. Lovejoy, VP.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Vivo Ventures VII Affiliates Fund, L.P. | — | — | 1 | $3.7M | 2015-07-21 |
| Albert Cha | Dir | — | 1 | $3.7M | 2015-07-21 |
| James N. Topper | Dir | — | 1 | $3.7M | 2015-07-21 |
| Peter A. Thompson | Dir | — | 1 | $3.0M | 2015-07-21 |
| Private Investments V. Lp OrbiMed | Dir | — | 1 | $3.0M | 2015-07-21 |
| Chandra D. Lovejoy | VP | — | 2 | $474K | 2016-01-12 |
| Nicholas Glover | CEOPres | — | 2 | $100K | 2016-01-15 |
| Wendy Chapman | SVP Clinical Operations | — | 1 | $47K | 2016-03-22 |
| Wendi Rodigueza | Chief Scientific Officer | — | 1 | $30K | 2016-01-22 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Wendy Chapman | SVP Clinical Operations | Sell | $21K | 2016-03-22 |
| Wendy Chapman | SVP Clinical Operations | Sell | $21K | 2016-02-22 |
| Wendy Chapman | SVP Clinical Operations | Sell | $94K | 2016-01-22 |
| Wendi Rodigueza | Chief Scientific Officer | Sell | $40K | 2016-01-20 |
| Nicholas Glover | President | Sell | $100K | 2016-01-15 |
| Nicholas Glover | CEO & President | Sell | $50K |
Companies that share insiders with DNAI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2016-01-15 |
| Chandra D. Lovejoy | SVP of Reg. Affairs & Quality | Sell | $474K | 2016-01-12 |
| Chandra D. Lovejoy | VP | Sell | $237K | 2016-01-12 |
| Private Investments V. Lp OrbiMed | Director | Buy | $3.0M | 2015-07-21 |
| Albert Cha | Director | Buy | $3.7M | 2015-07-21 |